Immunomic Therapeutics' Series B - II Round

Immunomic Therapeutics raised a round of funding on October 15, 2014.

Immunomic Therapeutics (ITI) is a clinical stage biotechnology company developing next generation vaccines based on LAMP Technology. The company's LAMP-vax platform increases the effectiveness of the …

Articles about Immunomic Therapeutics' Series B - II Round: